These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21320614)

  • 1. Osteoarthritis year 2010 in review: biochemical markers.
    Kraus VB
    Osteoarthritis Cartilage; 2011 Apr; 19(4):346-53. PubMed ID: 21320614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoarthritis year 2011 in review: biochemical markers of osteoarthritis: an overview of research and initiatives.
    Henrotin Y
    Osteoarthritis Cartilage; 2012 Mar; 20(3):215-7. PubMed ID: 22261406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoarthritis Year in Review 2016: biomarkers (biochemical markers).
    Mobasheri A; Bay-Jensen AC; van Spil WE; Larkin J; Levesque MC
    Osteoarthritis Cartilage; 2017 Feb; 25(2):199-208. PubMed ID: 28099838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summary of the OA biomarkers workshop 2009--biochemical biomarkers: biology, validation, and clinical studies.
    Kraus VB; Nevitt M; Sandell LJ
    Osteoarthritis Cartilage; 2010 Jun; 18(6):742-5. PubMed ID: 20206708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoarthritis year 2012 in review: biomarkers.
    Mobasheri A
    Osteoarthritis Cartilage; 2012 Dec; 20(12):1451-64. PubMed ID: 22842200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis.
    Kraus VB; Burnett B; Coindreau J; Cottrell S; Eyre D; Gendreau M; Gardiner J; Garnero P; Hardin J; Henrotin Y; Heinegård D; Ko A; Lohmander LS; Matthews G; Menetski J; Moskowitz R; Persiani S; Poole AR; Rousseau JC; Todman M;
    Osteoarthritis Cartilage; 2011 May; 19(5):515-42. PubMed ID: 21396468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for osteoarthritis: current position and steps towards further validation.
    Hunter DJ; Nevitt M; Losina E; Kraus V
    Best Pract Res Clin Rheumatol; 2014 Feb; 28(1):61-71. PubMed ID: 24792945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summary of the OA biomarkers workshop 2010 - genetics and genomics: new targets in OA.
    Meulenbelt I; Kraus VB; Sandell LJ; Loughlin J
    Osteoarthritis Cartilage; 2011 Sep; 19(9):1091-4. PubMed ID: 21723402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoarthritis year in review 2018: biology.
    Sherwood J
    Osteoarthritis Cartilage; 2019 Mar; 27(3):365-370. PubMed ID: 30808484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoarthritis year in review 2019: biomarkers (biochemical markers).
    van Spil WE; Szilagyi IA
    Osteoarthritis Cartilage; 2020 Mar; 28(3):296-315. PubMed ID: 31887390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoarthritis year in review 2023: metabolite and protein biomarkers.
    Liu M; Haque N; Huang J; Zhai G
    Osteoarthritis Cartilage; 2023 Nov; 31(11):1437-1453. PubMed ID: 37611797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoarthritis year in review 2015: soluble biomarkers and the BIPED criteria.
    Bay-Jensen AC; Reker D; Kjelgaard-Petersen CF; Mobasheri A; Karsdal MA; Ladel C; Henrotin Y; Thudium CS
    Osteoarthritis Cartilage; 2016 Jan; 24(1):9-20. PubMed ID: 26707988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the guinea pig.
    Kraus VB; Huebner JL; DeGroot J; Bendele A
    Osteoarthritis Cartilage; 2010 Oct; 18 Suppl 3(Suppl 3):S35-52. PubMed ID: 20864022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OARSI Clinical Trials Recommendations: Soluble biomarker assessments in clinical trials in osteoarthritis.
    Kraus VB; Blanco FJ; Englund M; Henrotin Y; Lohmander LS; Losina E; Önnerfjord P; Persiani S
    Osteoarthritis Cartilage; 2015 May; 23(5):686-97. PubMed ID: 25952342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass Spectrometry Imaging as a Potential Tool to Investigate Human Osteoarthritis at the Tissue Level.
    Lee YR; Briggs MT; Condina MR; Puddy H; Anderson PH; Hoffmann P; Kuliwaba JS
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoarthritis year 2010 in review: genetics.
    Loughlin J
    Osteoarthritis Cartilage; 2011 Apr; 19(4):342-5. PubMed ID: 21320617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoarthritis year 2012 in review: imaging.
    Roemer FW; Guermazi A
    Osteoarthritis Cartilage; 2012 Dec; 20(12):1440-6. PubMed ID: 22824160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoarthritis year in review 2017: biology.
    Appleton CT
    Osteoarthritis Cartilage; 2018 Mar; 26(3):296-303. PubMed ID: 29061493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of reference intervals for osteoarthritis-related soluble biomarkers: the FNIH/OARSI OA Biomarkers Consortium.
    Kraus VB; Hargrove DE; Hunter DJ; Renner JB; Jordan JM
    Ann Rheum Dis; 2017 Jan; 76(1):179-185. PubMed ID: 27343253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of Prospects of Biological Fluid Biomarkers in Osteoarthritis.
    Nguyen LT; Sharma AR; Chakraborty C; Saibaba B; Ahn ME; Lee SS
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.